Last quarter (Q ), Medite Cancer Diagnostics's total revenue was $2.39M, an increase of 41.99% from the same quarter last year. In Q, Medite Cancer Diagnostics's net income was $-757.00K. See Medite Cancer Diagnostics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 17	Dec 16	Dec 15	Dec 14	Dec 13
Total Revenue	$ 8.13M	$ 6.81M	$ 9.24M	$ 9.89M	$ 10.98M	$ 9.96M
Cost of Revenue	$ 6.21M	$ 6.65M	$ 5.61M	$ 6.08M	$ 7.16M	$ 5.75M
Gross Profit	$ 1.93M	$ 162.00K	$ 3.63M	$ 3.80M	$ 3.82M	$ 4.21M
Operating Expense	$ 5.94M	$ 6.64M	$ 5.29M	$ 4.40M	$ 4.21M	$ 3.92M
Operating Income	$ -4.01M	$ -6.48M	$ -1.66M	$ -599.00K	$ -394.00K	$ 294.00K
Net Non Operating Interest Income Expense	$ -2.03M	$ -849.00K	$ -694.00K	$ -204.00K	$ 276.00K	$ -266.00K
Other Income Expense	$ 233.00K	$ 31.00K	$ 60.00K	$ 22.00K	$ -75.00K	$ 45.00K
Pretax Income	$ -5.81M	$ -7.30M	$ -2.29M	$ -781.00K	$ -595.00K	$ 73.00K
Tax Provision	$ -487.00K	$ -487.00K	$ -132.00K	$ 78.00K	$ 104.00K	$ 19.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -5.42M	$ -6.90M	$ -2.25M	$ -937.00K	$ -808.00K	$ 54.00K
Basic EPS	$ -0.15	$ -0.26	$ -0.11	$ -0.05	$ -0.04	$ -1.00
Diluted EPS	$ -0.15	$ -0.26	$ -0.11	$ -0.05	$ -0.04	$ -1.00
Basic Average Shares	$ 196.58M	$ 26.44M	$ 21.42M	$ 20.19M	$ 18.12M	$ 1.97M
Diluted Average Shares	$ 196.58M	$ 26.44M	$ 21.42M	$ 20.19M	$ 18.12M	$ 1.97M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 12.15M	$ 13.29M	$ 10.90M	$ 10.49M	$ 11.38M	$ 9.66M
Net Income From Continuing And Discontinued Operation	$ -5.33M	$ -6.81M	$ -2.16M	$ -859.00K	$ -699.00K	$ 54.00K
Normalized Income	$ -5.33M	$ -6.66M	$ -2.16M	$ -872.20K	$ -650.25K	$ 20.71K
Interest Expense	$ 1.20M	-	-	-	$ 276.00K	$ 314.00K
EBIT	$ -3.82M	$ -6.48M	$ -1.66M	$ -599.00K	$ -394.00K	$ 387.00K
EBITDA	$ -3.54M	$ -6.19M	$ -1.45M	$ -422.00K	$ -224.00K	$ 589.00K

Currency in USD

Medite Cancer Diagnostics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing